Although previous studies have already confirmed these roles of CXCL12 in BLCA, we still chose CXCL12 as a representative of the many marker genes of iCAFs in this article to reveal aspects of iCAFs that were not well known in previous articles. This evidence concerns the gene CXCL12 and bladder transitional cell carcinoma.